C-Myc is a transcription factor that has been extensively studied due to its role as a proto-oncogene as it plays an important role in the control of proliferation, apoptosis and differentiation; its aberrant expression is seen in multiple human cancers, including acute myeloid leukaemia and pancreatic cancer. Here, MYC is linked to familial pancreatic carcinoma.